MODERATOR
:
A. Sergio Torloni, MD, Medical Director, Stem Cell Therapy, Therapeutic Apheresis, Mayo Clinic Hospital
SPEAKER
:
Rasheed Balagun, MD FACP FASN HP(ASCP), Associate Professor of Medicine, Asst. Dean of Student Affairs , Medical Director, Renal Unit & Extracorporeal Therapies, Division of Nephrology, University of Virginia
Description
This is a session focusing on the various forms of systemic conditions that lead to acute kidney injury (formerly acute renal failure) and concurrent upper or lower respiratory tract injury manifested as hemoptysis or other symptoms. The immunologic pathogenesis of these conditions will be discussed and the rationale to consider therapeutic apheresis as a logical therapeutic measure. There will be discussion of current and landmark clinical trials that involve the use of apheresis medicine as part treatment.
LEARNER OUTCOMES:
-
Classify pulmonary-renal syndromes.
-
Describe the pulmonary-renal syndromes.
-
Review of Evolution of Treatment Methods for pulmonary-renal syndromes.
-
Review pathogenesis of pulmonary-renal syndromes.
-
Review Recent and Landmark Clinical Trials that include Therepeutic Apheresis in the treatment of pulmonary-renal syndromes.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.9 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.